Surgery Partners, Inc. (NASDAQ: SGRY)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001638833
Market Cap 1.97 Bn
P/B 1.14
P/E -11.49
P/S 0.60
ROIC (Qtr) 9.10
Div Yield % 0.00
Rev 1y % (Qtr) 6.63
Total Debt (Qtr) 3.83 Bn
Debt/Equity (Qtr) 2.21

About

Surgery Partners, Inc., often recognized by its stock symbol SGRY, is a prominent player in the healthcare services industry. The company operates a national network of surgical facilities and ancillary services, with its headquarters situated in Franklin, Tennessee. Surgery Partners is engaged in two primary business segments. The first, Surgical Facility Services, involves the operation of ambulatory surgery centers (ASCs) and surgical hospitals. These facilities provide non-emergency surgical procedures across a spectrum of specialties. The...

Read more

Price action

Investment thesis

Bull case

  • Operating cash flow of 282.30M provides strong 12.17x coverage of stock compensation 23.20M, indicating sustainable incentive practices.
  • Strong operating cash flow of 282.30M provides 2.16x coverage of SG&A expenses 130.50M, showing efficient operational cost management.
  • Robust free cash flow of 238.10M exceeds capital expenditure of 44.20M by 5.39x, indicating strong organic growth funding capability.
  • Robust tangible asset base of 2.81B provides 5.45x coverage of working capital 516.20M, indicating strong operational backing.
  • Operating cash flow of 282.30M provides strong 3.06x coverage of inventory 92.30M, indicating efficient inventory management.

Bear case

  • Operating cash flow of 282.30M barely covers its investment activities of (232.20M), with a coverage ratio of -1.22, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 203.40M provide limited coverage of acquisition spending of (140.20M), which is -1.45x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • High receivables of 579.30M relative to inventory of 92.30M (6.28 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Operating earnings of 211.70M show weak coverage of depreciation charges of 188.80M, with a 1.12 ratio indicating high capital intensity and potential reinvestment needs.
  • High depreciation of 188.80M relative to operating cash flow of 282.30M, which is 0.67x suggests significant maintenance capital requirements affecting free cash flow.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.70 1.26
EV to Cash from Ops. EV/CFO 19.65 12.78
EV to Debt EV to Debt 1.45 12.10
EV to EBIT EV/EBIT 26.20 10.74
EV to EBITDA EV/EBITDA 9.68 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 23.29 18.02
EV to Market Cap EV to Market Cap 2.83 432.64
EV to Revenue EV/Rev 1.69 2.77
Price to Book Value [P/B] P/B 1.13 -1.92
Price to Earnings [P/E] P/E -11.42 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 0.82 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 48.84 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -8.30 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 237.45 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 11.39 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 35.10 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -13.24 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -189.36 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 44.39 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 11.45 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.41 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.35 0.39
Current Ratio Curr Ratio (Qtr) 1.88 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 2.21 -13.19
Interest Cover Ratio Int Coverage (Qtr) 0.82 -97.94
Times Interest Earned Times Interest Earned (Qtr) 0.82 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 12.20 -95.81
EBIT Margin % EBIT Margin % (Qtr) 6.44 -94.97
EBT Margin % EBT Margin % (Qtr) -1.41 -105.60
Gross Margin % Gross Margin % (Qtr) 23.90 23.31
Net Profit Margin % Net Margin % (Qtr) -5.20 -106.14